Richard Wlodarski, MD
Neurology · Glenview, ILNPI 1235516774
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,625 of the $3,885 with a category attached, or 93.3%. Sanofi accounts for 96.3% of it on its own, with 3 other manufacturers making up the rest.
Across 5 payments — averaging $776.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$4K
- Johnson & Johnson$99
- Novartis$31
- Kedrion Biopharma, Inc.$16
Across 64 payments — averaging $2006.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- H. Lundbeck A S$83K
- Argenx US, Inc.$29K
- Sanofi US Services Inc.$16K
What the payments were for
- Consulting fees$3,62593%
- Food & beverage$1614%
- Education$993%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 2 | $3,740 |
| Johnson & Johnson | 1 | $99 |
| Novartis | 1 | $31 |
| Kedrion Biopharma, Inc. | 1 | $16 |
How this compares
$3,885 in reported general payments places this provider in the 70th percentile of 790 neurology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Radicava OrsEdaravone | 61 | $860,301 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 13 | $112,676 |
| Droxidopa | 22 | $61,506 |
| Riluzole | 42 | $25,981 |
| NuedextaDextromethorphan Hbr/Quinidine | 16 | $23,938 |
| Gabapentin | 115 | $2,560 |
| Midodrine Hcl | 43 | $2,425 |
| Pyridostigmine Bromide | 32 | $2,024 |
| Duloxetine Hcl | 44 | $980 |
| Fludrocortisone Acetate | 56 | $703 |
| Pregabalin | 45 | $670 |
| Baclofen | 21 | $611 |
| Losartan Potassium | 45 | $379 |
| Prednisone | 67 | $371 |
| Nortriptyline Hcl | 15 | $334 |
Paid to pharmacies, not to this prescriber.
Other neurology in Glenview
- Trupti GokaniGlenview$126K
- Augusto MiravalleChicago$1.4M
- Lori GuytonHerrin$1.1M
- Daniel WynnNorthbrook$812K
- Arthur ItkinPalos Heights$808K
- Andrew GordonLake Barrington$765K
- Martha McGrawWinfield$625K
- Reuben ValenzuelaPeoria$590K
- Adil JavedChicago$584K
- Tyler KaplanMaywood$549K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.